Buy & Sell CureVac BV (CVAC) – CureVac BV Price Today
Key Stats
- $1.05BMarket Cap
- HealthSector
- -3M Drawdown
- $599.28MEnterprise Value
- -Dividend Yield
- 24 daysTypical Hold Time
CureVac BV (CVAC) is currently valued at a market capitalization of $1.05B, with an enterprise value of $599.28M. Over the past 52 weeks, CureVac BV has traded between a low of $2.59 and a high of $5.6, highlighting its annual price range. On average, investors hold CureVac BV for approximately 24 days, indicating typical investor behavior on the platform.
About CureVac BV
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GlaxoSmithKline to develop a second-generation COVID-19 vaccine. CureVac's first attempt to develop a COVID-19 vaccine did not have sufficient efficacy data, and its trials were discontinued in October 2021. The company's other pipeline candidates include mRNA vaccines for influenza, rabies, and malaria. Additionally, CureVac is in the early stages of development for oncology and molecular therapies spanning tumors, liver, ocular, and lung diseases.
Most Recent News
Rising U.S. Treasury yields block Bitcoin's breakout above $82,000 despite positive crypto news.
Bitcoin's recent attempts to break above $82,000 have been hindered by rising U.S. Treasury yields, with the 2-year yield hitting 4.09% and the 10-year surpassing 4.5%. Higher yields make low-risk government bonds more attractive, reducing appetite f...
S&P 500 retreats below 7,500 after brief surge, signaling possible market reset ahead of Nvidia earnings.
The S&P 500 closed at 7,408.50 on Friday, falling below the 7,500 level it briefly surpassed on Thursday, ending the week with a modest 0.3% gain. The recent surge to 7,517 appeared to be a mechanical, gamma-driven move with an expected reversal, inf...
Inflation rise and US-China trade talks spark volatility in Treasury yields, gold, silver, and stocks.
Recent inflation data shows accelerating price pressures, especially from energy costs, keeping the Federal Reserve cautious and supporting higher Treasury yields and a strong US dollar. The Trump-Xi meeting improved market sentiment but lacked confi...